Charles River Laboratories

CRL Common Stock USD0.01
Create an alert
Sell
$299.91
Buy
$300.07
$0.65 (0.22%)
Last updated today at
Trade
Back to dashboard

Company Information

About this company

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes businesses that provide foundational tools that enable its clients to discover new molecules: Research Models and Research Model Services. Its Discovery and Safety Assessment (DSA) segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including the in vitro, in vivo, and in silico studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Key people

Martin W. Mackay
Independent Chairman of the Board
Steven K. Barg
Independent Director
Abraham N. Ceesay
Independent Director
Mark Joseph Enyedy
Independent Director
Birgit Girshick
Chief Executive Officer
Glenn G. Coleman
Chief Financial Officer, Executive Vice President
Victoria L. Creamer
Corporate Executive Vice President, Chief People Officer
Mark Mintz
Executive Vice President, Chief Information Officer and Global Shared Services
Joseph W. Laplume
Corporate Executive Vice President - Corporate Development and Strategy
Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
James C. Foster
Non-Executive Director
Nancy C. Andrews
Independent Director
Click to see more

Key facts

  • Shares in issue
    49.56m
  • EPIC
    CRL
  • ISIN
    US1598641074
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $14.33bn
  • Employees
    18,300
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.